Vaccine Research and Development
COVID-19’s impact is first
collaboration across the biopharma industry
Operation Warp Speed
Clinical trials for COVID-19
The worldwide pandemic
therapeutics are in development
vaccines are in development
Vaccine platform technologies
vaccine candidates in development
vaccine candidates currently in development
vaccine candidates currently in development
Current timelines could
Allocating supply of a safe
Disclaimer vaccine development

To spotlight key assets in development, case studies have been developed to provide an asset-by-asset overview of development plans, timelines, and reasons for optimism.

Eileen Coveney, Managing Director
Jonathan Kfoury, Managing Director
Kevin Giffels, Senior Associate Consultant
Rosie Jiang, Global Healthcare Specialist

Please reach out to us if you would like to continue the discussion.

Related Insights